Investing Profile
David Goeddel
InvestorVC
Managing Partner at The Column Group
thecolumngroup.com/member/dav...Burlingame, California
Your Intro Paths to David Goeddel
Find David Goeddel on
cbCurrent Investing Position
The Column Group Managing Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
19
Current Fund Size
$600M
David Goeddel is on these Sector & Stage Rankings
Consumer Health (Series B)Pharmaceuticals (Seed)BioTech (Series B)Consumer Health (Series A)BioTech (Seed)Consumer Health (Seed)Pharmaceuticals (Series B)BioTech (Series A)Pharmaceuticals (Series A)Health IT (Series A)Health & Hospital Services (Series B)Health & Hospital Services (Series A)San Francisco Bay AreaDigital Health (Series B)Health IT (Seed)Health IT (Series B)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)
David Goeddel's Investments On Record (8)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Hexagon Bio | Series BOct 2022$77M Series UnknownSep 2021$61M Series ASep 2020$47M  | $190M |
Peloton Therapeutics | Series EFeb 2019$150M Series DSep 2016$52M Series AJul 2011$18M | $280M |
Exonics Therapeutics | Series ANov 2017$40M | $40M |
NGM Biopharmaceuticals | Series DMar 2015$58M Series BMar 2010$55M Series ADec 2009$27M | $260M |
Flexus Biosciences | Series BDec 2014$38M | $66M |
Nurix Therapeutics | Series BMay 2014$25M Series UnknownMar 2013$5M SeedMay 2012$3M | $150M |
Igenica | Series CJan 2014$14M Series CJun 2012$33M Series BJun 2010$24M Series AJan 2009$3M | $74M |
Constellation Pharmaceuticals | Series CJan 2012$95M | $390M |
Investors who invest with David Goeddel